Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Quiet and Underappreciated Rise of Drug-Resistant Invasive Fungal Pathogens
Amir Arastehfar, Cornelia Lass‐Flörl, Rocio Garcia‐Rubio, et al.
Journal of Fungi (2020) Vol. 6, Iss. 3, pp. 138-138
Open Access | Times Cited: 126

Showing 1-25 of 126 citing articles:

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin
Martin Hoenigl, Rosanne Sprute, Matthias Egger, et al.
Drugs (2021) Vol. 81, Iss. 15, pp. 1703-1729
Open Access | Times Cited: 313
COVID-19-Associated Candidiasis (CAC): An Underestimated Complication in the Absence of Immunological Predispositions?
Amir Arastehfar, Agostinho Carvalho, M. Hong Nguyen, et al.
Journal of Fungi (2020) Vol. 6, Iss. 4, pp. 211-211
Open Access | Times Cited: 248
Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium
Amir Arastehfar, Toni Gabaldón, Rocio Garcia‐Rubio, et al.
Antibiotics (2020) Vol. 9, Iss. 12, pp. 877-877
Open Access | Times Cited: 209
Aspergillus fumigatusand aspergillosis: From basics to clinics
Amir Arastehfar, Agostinho Carvalho, Jos Houbraken, et al.
Studies in Mycology (2021) Vol. 100, Iss. 1, pp. 100115-100115
Open Access | Times Cited: 163
Worldwide emergence of fluconazole-resistant Candida parapsilosis: current framework and future research roadmap
Farnaz Daneshnia, João Nóbrega de Almeida, Macit İlkit, et al.
The Lancet Microbe (2023) Vol. 4, Iss. 6, pp. e470-e480
Open Access | Times Cited: 111
Molecular Mechanisms Associated with Antifungal Resistance in Pathogenic Candida Species
Karolina Czajka, Krishnan Venkataraman, Danielle Brabant-Kirwan, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2655-2655
Open Access | Times Cited: 56
Fungal Drug Response and Antimicrobial Resistance
Paloma Osset-Trénor, Amparo Pascual‐Ahuir, Markus Proft
Journal of Fungi (2023) Vol. 9, Iss. 5, pp. 565-565
Open Access | Times Cited: 47
Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease
Martin Hoenigl, Amir Arastehfar, Maiken Cavling Arendrup, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 33
An Overview of the Recent Advances in Antimicrobial Resistance
Manuela Oliveira, Wilson Antunes, Salete Mota, et al.
Microorganisms (2024) Vol. 12, Iss. 9, pp. 1920-1920
Open Access | Times Cited: 25
Pan-Echinocandin-Resistant Candida glabrata Bloodstream Infection Complicating COVID-19: A Fatal Case Report
Brunella Posteraro, Riccardo Torelli, Antonietta Vella, et al.
Journal of Fungi (2020) Vol. 6, Iss. 3, pp. 163-163
Open Access | Times Cited: 87
Environmental Clonal Spread of Azole-Resistant Candida parapsilosis with Erg11-Y132F Mutation Causing a Large Candidemia Outbreak in a Brazilian Cancer Referral Center
Danilo Yamamoto Thomaz, João Nóbrega de Almeida, Odeli Nicole Encinas Sejas, et al.
Journal of Fungi (2021) Vol. 7, Iss. 4, pp. 259-259
Open Access | Times Cited: 66
Clonal Candidemia Outbreak by Candida parapsilosis Carrying Y132F in Turkey: Evolution of a Persisting Challenge
Amir Arastehfar, Süleyha Hilmioğlu Polat, Farnaz Daneshnia, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 59
Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic
Nuria Trevijano‐Contador, Alba Torres-Cano, Cristina Carballo-González, et al.
Open Forum Infectious Diseases (2022) Vol. 9, Iss. 11
Open Access | Times Cited: 39
Macrophage internalization creates a multidrug-tolerant fungal persister reservoir and facilitates the emergence of drug resistance
Amir Arastehfar, Farnaz Daneshnia, Nathaly Cabrera, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 30
Epidemiology of Invasive Candidiasis
Derek J. Bays, Emily N Jenkins, Meghan Lyman, et al.
Clinical Epidemiology (2024) Vol. Volume 16, pp. 549-566
Open Access | Times Cited: 10
Reshaping Echinocandin Antifungal Drugs To Circumvent Glucan Synthase Point‐Mutation‐Mediated Resistance
Moriah Jospe‐Kaufman, Efrat Ben‐Zeev, Austin Mottola, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 9
Open Access | Times Cited: 8
COVID-19 associated candidemia: From a shift in fungal epidemiology to a rise in azole drug resistance
Mohammad Javad Najafzadeh, Tahmineh Shaban, Hossein Zarrinfar, et al.
Medical Mycology (2024) Vol. 62, Iss. 4
Closed Access | Times Cited: 8
Nanotherapeutics and nanotheranostics in miscellaneous fungal infections
Amandeep Kaur, Khadga Raj, Prabha Rajput, et al.
Elsevier eBooks (2025), pp. 473-491
Closed Access | Times Cited: 1
What do we know about the biology of the emerging fungal pathogen of humans Candida auris?
Gustavo Bravo Ruiz, Alexander Lorenz
Microbiological Research (2020) Vol. 242, pp. 126621-126621
Open Access | Times Cited: 66
Evidence of Fluconazole-Resistant Candida parapsilosis Genotypes Spreading across Hospitals Located in Madrid, Spain and Harboring the Y132F ERG11p Substitution
Judith Díaz-García, Ana Gómez, Luís Alcalá, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 8
Open Access | Times Cited: 36
Invasive candidiasis: investigational drugs in the clinical development pipeline and mechanisms of action
Martin Hoenigl, Rosanne Sprute, Amir Arastehfar, et al.
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 8, pp. 795-812
Open Access | Times Cited: 35
Determinants of fluconazole resistance and echinocandin tolerance in C. parapsilosis isolates causing a large clonal candidemia outbreak among COVID-19 patients in a Brazilian ICU
Farnaz Daneshnia, João Nóbrega de Almeida, Amir Arastehfar, et al.
Emerging Microbes & Infections (2022) Vol. 11, Iss. 1, pp. 2264-2274
Open Access | Times Cited: 34
Candida parapsilosis complex in the clinical setting
Miriam Alisa Govrins, Cornelia Lass‐Flörl
Nature Reviews Microbiology (2023) Vol. 22, Iss. 1, pp. 46-59
Closed Access | Times Cited: 22
Coated Microneedle System for Delivery of Clotrimazole in Deep-Skin Mycoses
Barbara Jadach, Agata Nowak, Jolanta Długaszewska, et al.
Gels (2024) Vol. 10, Iss. 4, pp. 264-264
Open Access | Times Cited: 7
In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017–2022)
Michael A. Pfaller, Michael D. Huband, Paul Bien, et al.
Antimicrobial Agents and Chemotherapy (2024) Vol. 68, Iss. 2
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top